Journals / Kulak Burun Boğaz İhtisas Dergisi / 2002 / Cilt: 9 - Sayı: 5

The efficacy of droperidol, metoclopramide, profpofol and ondansetron for the prevention of nausea and vomiting following middle ear surgery

Orta kulak cerrahisi sonrası oluşan bulantı ve kusmada droperidol, metoklopramid, propofol ve ondansetronun etkinliği

Pages
331–336
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Droperidol and ondansetron seem to exert the highest efficacy to prevent nausea and vomiting during the postoperative 0 to 3 hours and 3 to 24 hours, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The efficacy and reliability of prophylactic antiemetic therapy with low dose propofol, droperidol, metoclopramide and ondansetron were evaluated in a randomized, double-blind, and prospective design.
📊
Key Findings & Data:Patients and Methods: A total of 101 ASA l-ll patients (34 females, 67 males; age range 16 to 53 years) undergoing middle ear surgery for chronic otitis media or its sequelae were randomly assigned to receive prophylactic antiemetic therapy with propofol (n=21, 0.5 mg/kg), droperidol (n=19, 20 mg/kg), metoclopramide (n=23, 0.2 mg/kg), ondansetron (n=21,4 mg), and placebo (n=20,0.9% NaCI).
💡
Conclusion & Impact:Conclusion: Droperidol and ondansetron seem to exert the highest efficacy to prevent nausea and vomiting during the postoperative 0 to 3 hours and 3 to 24 hours, respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Metoklopramid · Ameliyat sonrası bulantı ve kusma · Droperidol

Abstract

Objectives: The efficacy and reliability of prophylactic antiemetic therapy with low dose propofol, droperidol, metoclopramide and ondansetron were evaluated in a randomized, double-blind, and prospective design. Patients and Methods: A total of 101 ASA l-ll patients (34 females, 67 males; age range 16 to 53 years) undergoing middle ear surgery for chronic otitis media or its sequelae were randomly assigned to receive prophylactic antiemetic therapy with propofol (n=21, 0.5 mg/kg), droperidol (n=19, 20 mg/kg), metoclopramide (n=23, 0.2 mg/kg), ondansetron (n=21,4 mg), and placebo (n=20,0.9% NaCI). All drugs were administered intravenously five minutes before extubation. Results: In the early postoperative period (0 to 3 hours), the percentages of patients free from nausea and vomiting were 100% with droperidol, 71.4% with ondansetron and propofol, 52.1% with metoclopramide, and 35% with placebo. Ondansetron (90.4%) was found the most effective to pre-vent and control nausea and vomiting during the postoperative 3 to 24 hours, followed by droperidol (84.2%), propofol (57.1%), metoclopramide (47.8%), and placebo (40%). Compared with controls, the number of patients without nausea and vomiting was significantly greater in each treatment group but metoclopramide (p<0.05). No significant differences were detected with respect to adverse effects. Conclusion: Droperidol and ondansetron seem to exert the highest efficacy to prevent nausea and vomiting during the postoperative 0 to 3 hours and 3 to 24 hours, respectively.

Özet

Amaç: Orta kulak cerrahisi sonrası oluşan bulantı-kusmanın profilaktik tedavisinde düşük doz propofol, metoklopramid, ondansetron ve droperidolün etkinlik ve güvenilirliği rastgele seçimli, çift-kör ve prospektif bir çalışma düzeneğiyle araştırıldı. Hastalar ve Yöntemler: Kronik otit veya sekeli nedeniyle orta kulak cerrahisi uygulanan, ASA l-ll 101 hasta (34 kadın, 67 erkek; yaş dağılımı 16-53) rastgele seçimle beş gruba ayrıldı. Ekstübasyondan beş dakika önce her bir gruba propofol (n=21, 0.5 mg/kg), droperidol (n=19, 20 mg/kg), metoklopramid (n=23, 0.2 mg/kg), ondansetron (n=21, 4 mg) ve plasebo (n=20, %0.9 NaCI) intravenöz olarak uygulandı. Bulgular: Ameliyattan sonraki ilk üç saatlik dönemde droperidol alan hastaların hiçbirinde, ondansetron ve propofol gruplarının %71.4'ünde, metoklopramid grubunun %52.1'inde ye kontrol grubunun %35'inde bulantı-kusma görülmedi. Üç ile 24 saat arasındaki dönemde ise bulantı-kusmayı en iyi kontrol eden ajanın ondansetron (%90.4) olduğu görüldü; bunu droperidol (%84.2), propofol (%57.1), metoklopramid (%47.8) ve plasebo (%40) izledi. Erken ve geç dönemde bulantı-kusma görülmeyen hasta sayısı, metoklopramid grubu dışında, kontrol grubundan anlamlı derecede fazla bulundu (p<0.05). Gruplar arasında ilaçların yan etkileri açısından anlamlı fark görülmedi. Sonuç: Orta kulak cerrahisi sonrasında bulantı-kusmanın önlenmesinde erken dönemde droperidolün, geç dönemde ise ondansetronun daha etkili olduğunu saptadık.

🔖

Cite This Article

KARLIDAĞ, T., KAYGUSUZ, İ., BEŞTAŞ, A., KELEŞ, E., DEMİRBAĞ, E., YALÇIN, Ş. (2002). The efficacy of droperidol, metoclopramide, profpofol and ondansetron for the prevention of nausea and vomiting following middle ear surgery. Kulak Burun Boğaz İhtisas Dergisi, Cilt: 9 - Sayı: 5, 331–336. https://ajindex.com/articles/343135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Watcha MF, White PR Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84
  2. Honkavaara P, Saarnivaara L, Klemola UM. Prevention of nausea and vomiting with transdermal hyoscine in adults after middle ear surgery during general anaesthesia. Br J Anaesth 1994;73:763-6
  3. Reinhaçt DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesth Analg 1994;79:281-4
  4. Fujii Y, Toyooka H, Tanaka H. Granisetron reduces the incidence of nausea and vomiting after middle ear surgery. Br J Anaesth 1997;79:539-40
  5. Honkavaara P. Effect of transdermal hyoscine on nausea and vomiting during and after middle ear surgery under local anaesthesia. Br J Anaesth 1996;76:49-53
  6. Liu YH, Li MJ, Wang PC, Ho ST, Chang CF, Ho CM, et al. Use of dexamethasone on the prophylaxis of nausea and vomiting after tympanomastoid surgery. Laryngoscope 2001;lll:1271-4
  7. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 1996;76:316-8
  8. Fujii Y, Toyooka H, Tanaka H. Prophylactic anti-emetic therapy with granisetron, droperidol and metoclopramide in female patients undergoing middle earsurgery. Anaesthesia 1998;53:1165-8
  9. Fujii Y, Toyooka H, Tanaka H. Prophylactic antiemetic therapy with a combination of granisetron and dexamethasone in patients undergoing middle ear surgery. Br J Anaesth 1998;81:754-6
  10. Fujii Y, Tanaka H, Kobayashi N. Prevention of postoperative nausea and vomiting with antiemetics in patients undergoing middle ear surgery: comparison of a small dose of propofol with droperidol or metoclopramide.Arch Otolaryngol Head Neck Surg 2001;127:25-8
  11. Fujii Y, Tanaka H, Kobayashi N. Prevention of nausea and vomiting after middle ear surgery: granisetronversus ramosetron. Laryngoscope 1999;109:1988-90
  12. Borgeat A, Wilder-Smith OH, Saiah M, Rıfat K. Subhypnotic doses of propofol possess direct antiemeticproperties. Anesth Analg 1992;74:539-41
  13. Leeser J, Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist. Anesth Analg 1991;72:751-5
  14. Ishizaki H, Pyykko I, Aalto H, Starck J. Tullio phenomenon and postural stability: experimental study in normal subjects and patients with vertigo. Ann Otol Rhinol Laryngol 1991;100:976-83
  15. Yalçın Ş, Erhan ÖL, Akduracak O, Çelik O, Öztürk